| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0656897B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1169726A 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyrosine kinase medicated cellular proliferation |
| 01/07/1998 | CN1169722A 5-lipoxygenase inhibitors |
| 01/07/1998 | CN1169677A Use of pramipexole as nerveprotective agent |
| 01/07/1998 | CN1169429A Sulfamine-substituted benzodihydopyran, preparation method, use as medicine or diagnostic reagent and medicine containing same |
| 01/07/1998 | CN1169307A Guanmaiqutongning-medicine for treatment of migraine |
| 01/07/1998 | CN1169305A Oral liquor for treatonent of cardiovascular disease |
| 01/07/1998 | CN1169294A Medicine for treatment of obstruction of qi in chest by treating heart and stomach at same time |
| 01/07/1998 | CN1169291A External application powder composition and cloth-wetting agent |
| 01/07/1998 | CN1036918C Novel benzopyran derivatives and activating agent containing same |
| 01/06/1998 | US5705662 Hypotensive agents |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705531 Congestive heart failure and hypertension treatment |
| 01/06/1998 | US5705527 Amino acid derivatives |
| 01/06/1998 | US5705523 Thromboxane a2 synthetase inhibitors |
| 01/06/1998 | US5705509 Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists |
| 01/06/1998 | US5705504 Platelet activating factor |
| 01/06/1998 | US5705497 Inotropic, antiarrhythmia agents |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705388 CETP Ribozymes |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049708A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049682A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CN1168793A Injection adhesion and method for preparing same |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/30/1997 | US5703121 Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound |
| 12/30/1997 | US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger |
| 12/30/1997 | US5703113 Benzopyran derivatives |
| 12/30/1997 | US5703109 Cyanophenyl-1,2,4-triazole derivative |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703100 Modulators of acetylcholine receptors |
| 12/30/1997 | US5703099 Treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 12/30/1997 | US5703087 Phenyl indole compounds |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703052 Sterodial glycosides for treating hypercholesterolemia |
| 12/30/1997 | US5702696 For treatment of iron overload disorders |
| 12/30/1997 | CA2071629C Use of insulin sensitizing agents to treat hypertension |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0814087A2 Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/29/1997 | EP0814077A1 Benzoylguanidines, process for their preparation and medicaments containing them |
| 12/29/1997 | EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices |
| 12/29/1997 | EP0813871A1 Berberine derivates for inhibiting production of HSP47 |
| 12/29/1997 | EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 12/29/1997 | EP0813541A1 Process for producing a protein |
| 12/29/1997 | EP0813534A1 6-ARYL PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 12/29/1997 | EP0813533A1 SUBSTITUTED N-CYCLOALKYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4 AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813527A1 6-SUBSTITUTED PYRAZOLO 3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813420A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 12/29/1997 | EP0813416A1 Reduction of infarct volume using citicoline |
| 12/29/1997 | EP0813410A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 12/29/1997 | EP0569564B1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors |
| 12/24/1997 | WO1997048701A1 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| 12/24/1997 | WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |
| 12/24/1997 | WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997048401A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic |
| 12/24/1997 | WO1997048393A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | WO1997025333A3 Macrocyclic compounds made from suboxide units |
| 12/24/1997 | CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 12/24/1997 | CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A| pyrazin derivate |
| 12/24/1997 | CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof |
| 12/24/1997 | CA2258202A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic |
| 12/24/1997 | CA2257564A1 Use of green porphyrins in the manufacture of a medicament in the treatment of atherosclerosis without purposeful irradiation of the porphyrin derivatives |
| 12/23/1997 | US5700947 Having reduced side effects |
| 12/23/1997 | US5700839 Antiarrythmia agents; act as inhibitors of the cellular na+/h+ antiporter |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700818 Serotonin antagonists for treatment of nervous system, brain or psychological disorders |
| 12/23/1997 | US5700813 Treatment of thrombotic illness |
| 12/23/1997 | US5700812 Antispasmodic agent for cardiovascular disorder, antiserotonine agent |
| 12/23/1997 | US5700807 Endothelin receptor antagonists |
| 12/23/1997 | US5700803 Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| 12/23/1997 | US5700797 N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides |
| 12/23/1997 | US5700796 Useful for treating congestive heart failure, disease conditions with excess renal water reabsorption and conditions with increased vasular resistance and coronary vasoconstriction |
| 12/23/1997 | US5700788 Treatment of hiv |
| 12/23/1997 | US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines |
| 12/23/1997 | CA2126972C Styrene derivative and salts thereof |
| 12/23/1997 | CA2025855C Pharmaceutical compositions having activity on the cutaneous microcirculation |
| 12/20/1997 | CA2208174A1 Squalene synthetase inhibitors |
| 12/19/1997 | CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices |
| 12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
| 12/18/1997 | WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity |
| 12/18/1997 | WO1997047612A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 12/18/1997 | WO1997047310A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |